Filter
370
Text search:
International
Pharmaceutical
Federation
Featured
Recommendations
35
New Publications
84
Language
Document type
No document type
189
Studies & Reports
76
Guidelines
54
Manuals
19
Strategic & Response Plan
16
Training Material
9
Fact sheets
3
Situation Updates
2
Resource Platforms
2
Countries / Regions
Global
24
Nigeria
16
India
16
Western and Central Europe
13
Ukraine
11
Kenya
8
South Africa
8
Eastern Europe
6
Sierra Leone
4
Ethiopia
4
Eastern Europe and Central Asia
4
Africa
4
Russia
4
Liberia
3
Uganda
3
Syria
3
Asia
3
Senegal
2
Cameroon
2
Zimbabwe
2
Philippines
2
Nepal
2
Tanzania
2
Rwanda
2
Brazil
2
Lesotho
2
Myanmar / Burma
2
Latin America and the Carribbean
2
Moldova
2
Kyrgyzstan
2
Guinea
1
Congo, Democratic Republic of
1
Mali
1
Ghana
1
Niger
1
South Sudan
1
Iraq
1
Jordan
1
Germany
1
Chad
1
Bangladesh
1
Namibia
1
North Macedonia
1
Serbia
1
Botswana
1
Venezuela
1
Albania
1
Armenia
1
Laos
1
Tajikistan
1
Bulgaria
1
Uzbekistan
1
Kazakhstan
1
Georgia
1
Turkmenistan
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
92
Clinical Guidelines
35
Key Resources
25
Public Health
21
Women & Child Health
11
Pharmacy & Technologies
8
Capacity Building
7
Toolboxes
Pharmacy
33
Mental Health
32
HIV
30
TB
30
AMR
28
COVID-19
23
NCDs
20
Conflict
14
Rapid Response
12
Global Health Education
9
Planetary Health
8
Caregiver
7
Ebola & Marburg
5
Refugee
5
Specific Hazards
4
NTDs
4
Health Financing Toolbox
3
2.0 Rapid Response
3
Disability
2
Polio
2
Natural Hazards
2
Zika
1
Global concerns: Implications for the future
Child Mental Health Atlas
Guidance on TB and TB/HIV prevention, diagnosis, treatment and care in the workplace
Guidelines for Medicine Donations
recommended
This 3rd edition of Guidelines for medicine donations has been developed by the World Health Organization (WHO) in cooperation with major international agencies active in humanitarian relief and development assistance. The guidelines are intended to
...
The military offensive by the Russian Federation in Ukraine which began February 2022 has triggered one of the world’s fastest-growing displacement and humanitarian crisis, with geopolitical and economic ripples felt across the globe. The ongoing
...
Ukrainian Title:
УКРАЇНА: Еквівалентність лікарських засобів, зареєстрованих в Україні та інших країнах. Інформація для працівників охорони здоров'я та пацієнтів
To support t
...
Pandemic Influenza Risk Management
recommended
A WHO guide to inform & harmonize national & international pandemic preparedness and response
The main updates from the 2013 interim guidance are:
Alignment with other relevant United Nations policies for crisis and emergency management, and
...
Antimicrobial resistance (AMR) is a multifaceted, international public health problem, which poses a direct threat to the safety of the population of South Africa. A national response is required to complement the development of a global plan, as ar
...
The World Drug Report 2022 is aimed not only at fostering greater international cooperation to counter the impact of the world drug problem on health, governance and security, but also, with its special insights, at assisting Member States in antici
...
Globally each year, millions of people suffer illness or lose their lives because the vaccines, medicines and diagnostic tests that they need are either unavailable or unaffordable – and this lack of access to medicine is acute in low- and middle-in-
come countries (LMICs). While the COVID-19 pan
...
A case study from Bosnia and Herzegovina Eurasian Harm Reduction Network
The case study was prepared by Samir Ibisevic, President of PROI between March and June 2016 and edited by Graham Shaw.
EHRN is grateful to all who contributed to this document, especially: Dr. Serifa Godinjak, Chairperson
...
The article "Time to Align: Development Cooperation for the Prevention and Control of Non-Communicable Diseases" argues for greater international cooperation and investment in addressing non-communicable diseases (NCDs), especially in low- and middl
...
The Guidelines for the Diagnosis, Treatment and Prevention of Leprosy provide state-of-the-art knowledge and evidence on leprosy diagnosis, treatment and prevention based on a public health approach in endemic countries. The target audience of this document includes policy-makers in leprosy or infec
...
The aim of the present paper is to review capacity building in public health nutrition (PHN), the need for which has been stressed for many years by a range of academics, national and international organisations. Although great strides have been mad
...
This third booklet of the World Drug Report 2022 has a dual focus: opioids and cannabis.
The first chapter of the booklet provides an overview of opioids as a group of substances and their patterns of non-medical use at the global level. It also reviews the latest trends in the global supply of opi
...
The Global Burden of Disease (GBD) study, a collaborative endeavour of the World
Health Organization (WHO), the World Bank and the Harvard School of Public Health,
drew the attention of the international health community to the burden of neurologi
...
The UK government hosted the Global Vaccine Summit on June 4, 2020 under the patronage of the Rt. Hon. Boris Johnson, Prime Minister of the United Kingdom of Great Britain and Northern Ireland. The meeting was held by videoconference in light of the ongoing COVID-19 pandemic. 2. The Summit brought
...
Overcoming barriers in low- and middle-income countries
For the first time, this year’s report includes information on hepatitis C diagnostics. With a focus on selected countries with diverse HCV epidemics, the report provides updates on the various dimensions of access to HCV diagnostics and
...
Governments have dedicated a pivotal role to the private sector in the implementation and financing of the 2030 Agenda and the SDGs. This has pushed a turn towards the private sector, the promotion of multi-stakeholder partnerships between public and private actors. However, far too often there is a
...
The WHO laboratory biosecurity guidance follows and complements the revision of the Laboratory biosafety manual, fourth edition and provides principles and measures to prevent lapses and incidents throughout the whole value chain of handling high-consequence biological material, technology and infor
...
